Link – NovAccess Global

Providing Novel Diagnostics & Therapeutics in Cancer and Neurological Diseases

OTC Markets: XSNX

$0.67

+0.09 (15.52%)

June 20, 2021 2:50 PM

OTC Markets: XSNX

$0.67

+0.09

(15.52%)

June 20, 2021 2:44 PM

/

Link

NovAccess Global Acquires StemVax Therapeutics from Innovest Global

By ivst_adminIn NovAccess Global Press ReleasesPosted September 9, 2020

XsunX, Inc. Changes Name to NovAccess Global Inc.

By ivst_adminIn NovAccess Global Press ReleasesPosted August 26, 2020

Innovest Global Announces Upcoming Conference Participation and Biotech Award

By ivst_adminIn NovAccess Global Press ReleasesPosted September 4, 2019

Innovest Board Approves Plan to Maximize Shareholder Value from Biotech and Industrial Initiatives

By ivst_adminIn NovAccess Global Press ReleasesPosted July 22, 2019

Innovest Global Provides December Shareholder Update Featuring Acquisition Update, Revenue Growth, Biotech Progress

By ivst_adminIn NovAccess Global Press ReleasesPosted December 17, 2018

Innovest Global Biotech Partners with Preeminent Los Angeles Association

By ivst_adminIn NovAccess Global Press ReleasesPosted December 10, 2018

Innovest Global Announces Elite Biotech Team

By ivst_adminIn NovAccess Global Press ReleasesPosted November 29, 2018

Innovest Global Biotech Division Sets Fall Conference Schedule

By ivst_adminIn NovAccess Global Press ReleasesPosted August 24, 2018

Innovest Global Biotech Division Sets Fall Conference Schedule

By ivst_adminIn NovAccess Global Press ReleasesPosted August 24, 2018

Innovest Global Provides August Shareholder Update with Milestones Including Patent Approval, Biotech Progress, Financial Achievements

By ivst_adminIn NovAccess Global Press ReleasesPosted August 13, 2018